Helios Study Touts Drug Testing, but Experts Warn of another Cost Driver

While the U.S. engages in a broad effort to reduce opioid prescriptions, new research suggests that workers’ compensation payers can reduce drug costs after drugs are prescribed. Helios, a pharmacy benefit management company, announced the results Tuesday of several studies examining the impact of its four-year-old Drug Testing and Monitoring program. According to study authors Matthew Foster and Brooke Mueller, the program enrolls claimants who exhibit multiple risk factors for misuse and abuse of prescription drugs, such as use of multiple pharmacies, prescriptions of chronic opioid ...